Has an AI model identified a potential drug for your condition that’s ready to be validated in a clinical trial?
Join our upcoming webinar exploring the latest Cures Within Reach funding opportunity – hosted in partnership with REMEDi4ALL and Cures Within Reach!
Artificial intelligence (AI) is increasingly seen as a powerful tool in the search for new treatments – especially through drug repurposing. By analysing large sets of data, AI can help identify existing medicines that might work for different conditions.
This is particularly valuable in rare diseases, where repurposing offers a potentially faster, more cost-effective path to finding treatment options.
You can read more about drug repurposing here.
AI has shown promise in supporting this process, but a key question remains:
Do AI-generated predictions actually work when tested in real-life clinical trials?
Cures Within Reach is helping to explore this question through a new funding call.
They’re inviting letters of intent for Phase I/IIA clinical trials that will test and validate AI-based repurposing ideas, with a preference for rare disease. The aim is to build the evidence needed to validate and improve the AI models to help find treatments that work in real-world settings.
You can visit https://bit.ly/cwrrfps for more information.
So what does this look like in practice, and how can patient groups take part?
Join us in this webinar to find out!
Up to $100,000 in funding is available for early-stage clinical trials (Phase I or IIA) that test existing drugs or therapies for new uses, identified through AI models
Additional funding is available to support community engagement alongside the trial
Eligible trials must be based on AI-generated data that supports the repurposing idea
The call is open to any unsolved disease, but there’s a strong preference for rare conditions and for using off-patent treatments
What will we cover in this webinar?
- A breakdown of what this funding call is about
- Advice from Cures Within Reach on what makes a strong application
- How patient groups can get involved in applications
- A practical example of a patient group contributing to an AI-led initiative
- The opportunity to ask any questions you might have to the Cures Within Reach team
Meet the speakers
Clare Thibodeaux, PhD is Vice President of Scientific Affairs at Cures Within Reach, where she leads the organisation’s scientific initiatives and grant review processes.
With nearly 20 years of experience in research and philanthropy, Clare works closely with researchers, patient advocates, and industry partners to drive forward clinical trials in drug repurposing. She also serves on the Advisory Board for the CURE Drug Repurposing Collaboratory and plays a key role in developing funding calls.
CJ Wright serves as the Director, Scientific Affairs at Cures Within Reach. He joined the team in 2024 after graduating from Purdue University with his PharmD. CJ has experience at large and small pharmaceutical companies, academic health centers and regional hospitals and consulting companies.
He supports Cures Within Reach’s funding opportunities, works with the Grant Review Committee, manages post-award grants reporting and assists with other scientific initiatives.
Who is this webinar for?
This session is open to any patient group interested in learning more about this unique funding opportunity – including patient groups already involved in AI-driven clinical research, as well as those looking to better understand how AI can support drug repurposing.
No technical AI experience is needed – the session is designed to be accessible regardless of where you are on your journey!
Join this webinar to learn more about this funding call and how your patient group can contribute to a successful application!
Please note: the ticket window may take a few seconds to load.
To secure your order, please ensure you complete the form in its entirety.
